Mankind Pharma Limited has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of INR 13,768 Crores. This strategic move marks a significant leap for Mankind Pharma, positioning it as a market leader in the Indian
Expands high entry barrier portfolio; Leadership in Women’s Health (#1 in Gynae IPM[i]) High entry barrier portfolio with specialty R&D tech platforms across - Recombinants, Niche Biologics, Novel Delivery and Immunoglobulins Only innovator in the world to develop patented recombinant Anti-D Brands across Women’s Health
Bharat Serums and Vaccines Limited (BSV) joined hands with Sir JJ School of Arts to bring to life, the concept of ‘wellness and good health’ through the medium of art. A group of twelve students, from the Fine Arts School, were chosen to showcase their
Bharat Serums and Vaccines (BSV), a leading biopharmaceutical company in India reaffirms its commitment to spur innovation and scientific research through its world class R&D centre at Airoli, Maharashtra. The state-of-art centre was inaugurated by Shri Rajesh Tope, Maharashtra's Health Minister yesterday. Also present at
